Final ID: Mo2136
Optimizing Outcomes in Atrial Fibrillation - Where Do We Go from Here?
Monday, 11/18/2024 , 01:30PM - 02:30PM
Abstract Poster Session
Ali Ahmed, Goda Ahmed, Abozied Omar, Egbe Alexander
A Phase 2a randomized controlled trial of once-daily versus twice-daily remote ischemic conditioning in vascular cognitive impairment (TRIC-VCI)Ganesh Aravind, Mccreary Cheryl, Sahlas Demetrios, Sharma Mukul, Swartz Richard, Smith Eric, Barber Philip, Black Sandra, Corbett Dale, Field Thalia, Frayne Richard, Hachinski Vladimir, Ismail Zahinoor, Mai Lauren
Rennison Julie, Smith Jonathan, Chung Mina, Barnard John, Van Wagoner David, Cantlay Catherine, Li Ling, Lovano Beth, Castel Laurie, Cantlay Paul, Gillinov A, Moravec Christine, Willard Belinda
Randomized Controlled Trial of Metformin and Lifestyle/Risk Factor Modification for Upstream Prevention of Atrial Fibrillation Progression: The Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) TrialChung Mina, Cantlay Catherine, Crookshanks Michael, Mchale Megan, Lovano Beth, Castel Laurie, Park Kevin, Foster Parker, Guo Lydia, Yang Lucy, Sullivan Erin, Wass Sojin, Jin Alison, Cantlay Paul, Varma Niraj, Barzilai Benico, Bruemmer Dennis, Cho Leslie, Huang Julie, Hussein Ayman, Kashyap Sangeeta, Xlaffinx Xlukex, Sun Han, Mehra Reena, Moravec Christine, Saliba Walid, Wazni Oussama, Sanders Prashanthan, Nissen Steven, Van Iterson Erik, Smith Jonathan, Van Wagoner David, Barnard John, Kim Hyun Su, Schilling Taylor, Telfer William, Lissemore Frances, Bibidakis Dimitra, Lin Cheryl